Nab-paclitaxel and gemcitabine or FOLFIRINOX as first-line treatment in patients with unresectable adenocarcinoma of the pancreas: does sequence matter?

BACKGROUND: Locally advanced or metastatic adenocarcinoma of the pancreas remains - despite the implementation of new chemotherapy protocols - a disease with short overall survival (OS). METHODS: Eighty-three patients were treated with locally advanced or metastatic adenocarcinoma of the pancreas wi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Vogl, Ursula M., Andalibi, Haleh, Klaus, Alexander, Vormittag, Laurenz, Schima, Wolfgang, Heinrich, Bettina, Kafka, Alice, Winkler, Thomas, Öhler, Leopold
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6325849/
https://ncbi.nlm.nih.gov/pubmed/30621630
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-5240-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados